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Background & aims: Associations of dietary sugars with metabolic and inﬂammatory markers may vary
according to the source of the sugars. The aim of this study was to examine the association of dietary
sugars from different sources [beverages (liquids), foods (solids), extrinsic (free) or intrinsic (non-free)]
with metabolic and inﬂammatory markers.
Methods: Population-based cross-sectional study of adults in the East of England (n ¼ 9678). Sugar in-
takes were estimated using food frequency questionnaires. Fasting glycated haemoglobin, glucose, in-
sulin, and C-Reactive Protein (CRP) were measured and indices of metabolic risk were derived
(homeostatic model of insulin resistance, HOMA-IR and metabolic risk z-score).
Results: In multiple linear regression analyses adjusted for potential confounders including BMI and TEI,
sugars from liquids were positively associated with ln-CRP [b-coefﬁcient (95%CI), 0.14 (0.05,0.22) per 10%
TEI] and metabolic risk z-score [0.13 (0.07,0.18)]. Free sugars were positively associated with ln-HOMA-IR
[0.05 (0.03,0.08)] and metabolic risk z-score [0.09 (0.06,0.12)]. Sugars from solids were not associated
with any outcome. Among major dietary contributors to intakes (g/d), sugars in fruit, vegetables, dairy
products/egg dishes, cakes/biscuits/confectionary and squash/juice drinks were not associated, but sugar
added to tea, coffee, cereal was signiﬁcantly positively associated with all outcomes. Sugars in 100% juice
[0.16 (0.06,0.25) per 10%TEI] and other non-alcoholic beverages [0.13 (0.03,0.23)] were positively asso-
ciated with metabolic risk z-score.
Conclusion: Higher intakes of sugars from non-alcoholic beverages and sugar added to tea, coffee, cereal
were associated with glycaemia and inﬂammatory markers. Sugars from solids were not associated,
irrespective of whether they were intrinsic or extrinsic. Positive associations of free sugars were largely
explained by contribution of beverages to intake.
© 2017 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license
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The role of dietary sugars in the aetiology of cardio-metabolic
disease has been long debated [1,2]. As cardio-metabolic diseases
are largely preventable, the identiﬁcation of modiﬁable factors that
inﬂuence the pathogenesis of these diseases is central to combat-
ting their onset. Thus, the association of dietary sugars with cardio-
metabolic disease warrants further attention and clariﬁcation.
In recent years evidence has accumulated that dietary sugars are
associated with increased body-weight, as summarised in a large
meta-analysis of 30 randomised controlled trials and 38 cohort
studies [3]. It is now widely accepted that dietary sugars promotele under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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L. O'Connor et al. / Clinical Nutrition xxx (2017) 1e102adverse metabolic outcomes via weight-gain through their
contribution to energy intake. There is also emerging evidence that
dietary sugars, including sucrose or other mono- and di-
saccharides or free sugars intake, are associated with increased
blood pressure and serum lipids, independently of body fat [4].
There is thus a suggestion that dietary sugars may also be associ-
ated with increased metabolic risk, independently of energy intake
and body-weight.
Dietary sugars are a complex component of the diet and their
effects on health outcomes are likely to differ depending on the
properties of the consumed sugars, including chemical composi-
tion (e.g. glucose versus fructose), and the source of the sugars, e.g.
from beverage or food sources or, extrinsic or intrinsic cellular
location in the food. However, research focus to date has largely
been on the health effects associated with intakes of total sugars
[5], added sugars [6], individual sugars, in particular fructose [7]
and intakes of sugary beverages [8,9] but evidence for differential
association of sugars from different sources with different physical
properties is limited.
The aim of this study was to examine the association between
intakes of dietary sugars from different sources [beverages (sugars
from liquids), food (sugars from solids), extrinsic (free) sugars,
intrinsic (non-free) sugars] and metabolic markers including, gly-
cated haemoglobin (HbA1c), homeostasis model assessment of in-
sulin resistance (HOMA-IR), C-reactive protein (CRP) and a
metabolic risk z-score.
2. Materials and methods
2.1. Study design and population
The Fenland Study is a population-based observational study.
Participants born between 1950 and 1975 were recruited from
general practice lists in and around Cambridgeshire, in the East of
England, UK. In total, 12,434 participants were enrolled between
2005 and 2015. Exclusion criteria of the Fenland study included
pregnancy, physician-diagnosed diabetes, inability towalk unaided,
psychosis, or terminal illness. Participants missing any exposure or
outcome data (n ¼ 2754) and participants with extremely high
intakes of total sugars (n¼ 2) (Supplementary Fig.1) were excluded,
leaving 9678 participants for inclusion in these analyses. Ethical
approval was granted by the Cambridge Local Research Ethics
Committee. All participants gave written informed consent.
2.2. Dietary assessment
Habitual diet over the previous year was self-reported using a
validated 130 item semi-quantitative food frequency questionnaire
(FFQ) [10]. Total energy intake, nutrient intake including intake of
total sugars, and food group intakes were estimated as previously
described [11], using the UK's food compositional tables, McCance
andWiddowson's,TheCompositionof Foods. In avalidation study, the
Spearman correlation coefﬁcient between individual results from
16-day weighed dietary records and FFQs for total sugar (g/d) was
0.51 with 44% of participants classiﬁed into the same quartiles of
intakes, 51% in adjacent quartiles and 5% into extreme quartiles [12].
Total sugars included monosaccharides and disaccharides from
all sources. Intakes of sugars from liquids, sugars from solids, free-
sugars and non-free-sugars were estimated post hoc by categoris-
ing food sources as follows. Sugars from liquids were estimated as
total sugars from beverages which included: teas, coffees, hot-
chocolate, malted-milk drinks, alcoholic beverages, ﬁzzy drinks,
fruit juice and fruit squash. Sugars from solids were estimated as
total sugars from foods. Foods included all foods including semi-
solid foods like yoghurt and soups. In primary analyses, milk wasPlease cite this article in press as: O'Connor L, et al., Intakes and sources of
markers, Clinical Nutrition (2017), http://dx.doi.org/10.1016/j.clnu.2017.0excluded from sugars in liquids or solids as it was not discerned
using the FFQ whether milk was consumed as a beverage or in food
e.g. milk in cereal or composite dishes: the inﬂuence of this deci-
sion was assessed in sensitivity analysis (see below). Information
on table sugar added to tea, coffee, cereal was collected as a sepa-
rate single question in the FFQ and could not be directly linked to
the food or beverage with which it was consumed. As such all table
sugar added to tea, coffee, or cereal by the participant was included
as sugars from solids.
Free sugars were estimated according to the Scientiﬁc Advisory
Committee of Nutrition's (SACN's) and the World Health Organi-
sation's (WHO's) deﬁnition [5], and were calculated using a com-
bination of published methods [13] as no single method was fully
comprehensive. Free sugars included: 100% of total sugar from fruit
juice, table sugar, honey, syrups; 100% of sugar in processed foods
where the unprocessed product has no naturally occurring sugar
e.g. meat; 50% of total sugar in processed foods which also had
naturally occurring sugar e.g. reﬁned cereal, baked beans. Sugar in
milk was excluded but, sugar in dairy products and milk based
beverages was included as: total sugar minus lactose. Sugars in
canned, stewed and dried fruit were not included as free sugars as
per SACN's and the WHO's deﬁnition but, sugar in sweetened
versions of these, e.g., fruit canned in syrup was included as sugar
in sweetened product minus sugar in unsweetened product. Non-
free sugars were estimated as total sugars minus free sugars.
2.3. Clinical and biochemical measurements
Height, weight, waist circumference and blood pressure were
measured and BMI was calculated using standardised methods
(Supplementary text). Fasting venous blood samples were taken
and were followed by a standard 75 g oral glucose tolerance test
with further samples taken at 120 min. Plasma glucose, tri-
glycerides (TG) HDL cholesterol, insulin, HbA1c and CRP levels were
measured using standardised techniques (Supplementary text).
HOMA-IR was calculated to evaluate insulin resistance (fasting in-
sulin (mU/ml)  fasting plasma glucose (mmol/L)/22.5).
We constructed a standardised continuous variable for the
metabolic risk, broadly based on the deﬁnition proposed by the
WHO and described previously in detail [14,15]. The variable was
derived by summing the z-scores of continuous indices of anthro-
pometry (waist circumference), blood pressure (systolic blood
pressure and diastolic blood pressure), glycaemia (2-h plasma
glucose), insulin (fasting insulin), lipids (inverted fasting HDL
cholesterol) and triglycerides. The summed score was further
scaled to have one standard deviation and hereafter referred to as
the metabolic risk z-score.
2.4. Covariates
Self-reported demographic, lifestyle and health variables were
collected using a questionnaire. These included age, sex, marital
status (single, married, widowed/separated/divorced), age at
completion of full-time education, income level (<£20,000,
£20,000e£40,000, >£40,000), social class (routine and manual oc-
cupations, intermediate occupations and higher managerial,
administrative and professional occupations), smoking status
(never, former, current), alcohol intake (units/week), and being on a
weight-loss diet (yes, no). Information on test site location (Ely,
Wisbech, Cambridge), self-reported hypertension or hyper-
lipidaemia and the use of anti-hypertensive and lipid lowering
medication were also recorded. Physical activity was objectively
assessed over 6 days using a combined heart rate and movement
sensor (Actiheart, CamNTech, Cambridge, UK), with individual
calibration of heart rate performed using a treadmill test. Data fromdietary sugars and their associationwithmetabolic and inﬂammatory
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equation framework to estimate intensity time-series, which were
summarised over time as daily Physical Activity Energy Expendi-
ture (PAEE) (kJ/kg/d) [16]. Plasma vitamin C is an objective marker
of fruit and vegetable intake [17] and was used here as a proxy of
dietary quality. For plasma vitamin C measurement, blood samples
were taken into heparin tubes, centrifuged, aliquoted, stabilised
with metaphosphoric acid, and stored (detail in Supplementary
text). Plasma vitamin C concentration was measured by ﬂuoro-
metric assay within 2 months.
Participants with missing covariate data were retained for
analysis; missing data in categorical variables were coded as
missing. Where objectively measured physical activity measure-
ment was not available (n ¼ 102), self-reported data from a vali-
dated questionnaire, the Recent Physical Activity Questionnaire
(RPAQ) [18] were used. Where age at completion of full-time ed-
ucation was not available (n ¼ 270), we used the mean of a
matched sample based on age, sex, household income level and
social class.
2.5. Statistics
Population characteristics of the total study population
(n ¼ 12,434) were compared with those excluded from the analysis
(n ¼ 2756). Intakes of sugars from liquids, sugars from solids, free
sugars and non-free sugars were expressed as % contribution to
total energy intake (%TEI). Each sugar exposure (%TEI) was split by
quintile into consumption categories. The population characteris-
tics [mean ± standard deviation (SD), median (inter-quartile range)
or percent] of the highest consumption category were compared
with those of the lowest consumption category for each sugar
intake exposure. P-values for trend for population characteristics
were estimated across quintiles using ANOVA or chi-squared for
independence.
We used multiple linear regression to assess the categorical
(quintile) and continuous (per 10%TEI) associations of each sugar
intake exposure with HbA1c, HOMA-IR, CRP and the metabolic risk
z-score. HOMA-IR and CRP were natural-log (ln) transformed. P-
values for trend across quintiles were estimated by including the
median value of each quintile and modelling as a continuous var-
iable. Model 1 was adjusted for age, sex, years of education, income
level, social class, smoking status, alcohol consumption, test site,
PAEE, clinical history (self-reported medication use for hyperten-
sion or hyperlipidaemia), self-reported weight-loss diet (yes/no),
ﬁbre (non-starch polysaccharides, NSP) intake and plasma vitamin
C measurement as proxies of dietary quality, non-sugar containing
beverage intake (tea, coffee and artiﬁcially sweetened beverages)
and low-nutrient energy-dense food intake (buns, cakes, puddings,
biscuits, pastries, chocolates and non-chocolate confectionary and
ice-cream). Model 2 was additionally adjusted for BMI, energy
intake and mutually adjusted for intakes of other sugars.
A number of sensitivity analyses and tests for interaction were
pre-speciﬁed. Sensitivity analyses included: [1] using energy
partition and residual methods [19] in place of the above-
mentioned nutrient density (%TEI) approach, to characterise the
inﬂuence of TEI; [2] including total sugars frommilk as sugars from
liquids; [3] including sugar added to tea, coffee, cereal as sugars
from liquids rather than sugars from solids; [4] restricting analyses
of HbA1c to participants with levels of HbA1c < 6.5% (thus excluding
those potentially with undiagnosed T2D). Possible interactions
with age (continuous), sex (dichotomous), BMI (continuous), PAEE
(continuous) and smoking status (dichotomous) were examined by
including each interaction term with a sugar exposure in Model 2.
Where interactions were signiﬁcant (p < 0.05), stratiﬁed analyses
were conducted.Please cite this article in press as: O'Connor L, et al., Intakes and sources of
markers, Clinical Nutrition (2017), http://dx.doi.org/10.1016/j.clnu.2017.05Macronutrient substitution models were also constructed to
examine the effect of replacing sugars with each of polyols, oligo-
saccharides and starch, total fat, and total protein (using Model 2)
[19]. We assessed the association of sugars from liquids, sugars
from solids, free sugars and non-free sugars (per 10%TEI) with the
individual components of the metabolic risk z-score using Model 2.
Fasting insulin and triglycerides were natural log (ln) transformed.
We identiﬁed major food and beverage contributors to intake of
each of sugars from liquids, sugars from solids, free sugars and non-
free sugar as those that contributed >10% of intake (g/d) of each
sugar exposure. We then examined the associations of sugars from
each of the major foods and beverage contributors with HbA1c, ln
HOMA-IR, ln CRP and the metabolic risk z-score, using Model 2
which was mutually adjusted for sugars from all other sources.
Intakes of dietary sugars and their major food and beverage
contributors were reported by BMI status (normal weight (<25 kg/
m2), overweight (25e30 kg/m2), obese (>30 kg/m2)) to inform our
interpretation of results given the possibility of reverse causality in
cross-sectional analyses.
The analyses were performed using Stata (version 13; Stata
Corp, TX, USA). Statistical signiﬁcance was set at p  0.003 to ac-
count for multiple testing (4 exposures  4 outcomes).3. Results
3.1. Intakes and sources of dietary sugars
The mean ± SD intake of total sugars in this study population
was 124 ± 53 g/d, representing 23.6 ± 6.0%TEI (Fig. 1). The majority
(85%) of total sugars were consumed as sugars from solids,
20.0 ± 5.8%TEI. Sugars from liquids contributed only a small
amount (12%) to intake of total sugars, 2.9 ± 2.6%TEI, and there
were 10% non-consumers in this population. All sugars from liquids
and 45% of sugars from solids were consumed as free sugars. Free
sugars and non-free sugars contributed similarly (50% each) to
intake of total sugars, 12.0 ± 4.8 and 11.6 ± 5.2 %TEI, respectively.3.2. Population characteristics
Population characteristics of the total study population included
for analyses (n¼ 9678) and those excluded due tomissing exposure
or outcome data (n ¼ 2756) were broadly similar (Supplementary
Table 1).
Table 1 shows the population characteristics by consumption
category (quintile) of each of sugars from liquids, sugars from
solids, free sugars and non-free sugars. Thosewith higher intakes of
sugars from liquids were more likely to be younger, to bemen, to be
single, to have a higher BMI and to consume more alcohol. They
were also more likely to have a higher education level, household
income and social class, to smoke less and to have higher PAEE.
Participants with higher intakes of free sugar weremore likely to be
younger and to be men, with lower education, household income
and social class and to smoke more, but also to have higher PAEE
and consume less alcohol. Socio-demographic characteristics by
consumption category of sugars from solids and non-free sugars
were similar to each other and were largely in the opposite direc-
tion to that for free sugars.
Higher intake of each source of sugars was associated with
lower total fat and starch (%TEI) and higher total carbohydrates and
total sugars (%TEI). Higher intakes of sugars from liquids and free
sugars were associated with higher energy intake and lower pro-
tein (%TEI), ﬁbre (g/d) and vegetable intake. For intakes of sugars
from solids and non-free sugars, these associations with dietary
intakes were in the opposite direction.dietary sugars and their associationwithmetabolic and inﬂammatory
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Fig. 1. Contribution of dietary sources of sugars to intakes of total sugars (%TEI); The Fenland Study, UK (n ¼ 9678). Abbreviations: Percent Total Energy Intake, %TEI. Values are:
mean ± SD (range). *Milk sugars were not included as an exposure in these analyses as the food frequency questionnaire did not enable determining if milk was consumed as a
beverage or in a composite food.
L. O'Connor et al. / Clinical Nutrition xxx (2017) 1e104Notably, there was no difference in fruit intake across the con-
sumption categories of sugars from liquids, although those with
higher intakes of sugars from liquids had higher plasma vitamin C
measurements. Both fruit intake and plasma vitamin C levels were
higher in those with higher intakes of sugars from solids and non-
free sugars. Those with higher intakes of free sugars had lower
intakes of fruit and lower plasma vitamin C levels.
3.3. Metabolic and inﬂammatory markers
After correction for multiple testing (a ¼ 0.003), intake of sugars
from liquids (%TEI) was positively associated with ln HOMA-IR [Q5
versus Q1: b-coefﬁcient (95% conﬁdence intervals, 95%CI), 0.11
(0.07,0.15), p-trend< 0.001], ln CRP [0.21 (0.13,0.28), p-trend< 0.001]
and the metabolic risk z-score [0.18 (0.13,0.24), p-trend < 0.001] and
not signiﬁcantly associated with HbA1c [0.00 (0.01,0.04), p-
trend ¼ 0.058] (Model 1, Table 2). Adjustment for BMI, TEI and
mutual adjustment for sugars (Model 2) attenuated themagnitude of
the associations but they remained signiﬁcantly positively associ-
ated. Higher intakes of free sugars were positively associated with ln
HOMA-IR and the metabolic risk z-score [Q5 versus Q1: b-coefﬁcient
(95%CI), 0.08 (0.04,0.12), p-trend < 0.001 and 0.13 (0.08,0.17), p-
trend< 0.001], Model 2. Intakes of sugars from solids and of non-free
sugars were inversely associated with ln HOMA-IR when highest
consumers (Q5)were comparedwith lowest consumers (Q1) (Model
1). The association of sugars from solids was attenuated to the null
after adjustment for BMI, TEI and mutual adjustment (Model 2). The
association of non-free sugars was attenuated slightly but remained
signiﬁcant after further adjustment [b-coefﬁcient (95%CI),0.07
(0.11,0.03), p-trend ¼ 0.001].
Associations using continuous measures (per 10%TEI) were
similar to those using categorical measures and are displayed in
Fig. 2 (additional detail in Supplementary Table 2).
Estimates were also largely similar when substitution with total
fat, total protein and, polyols, oligosaccharides and starch was
speciﬁed (Supplementary Table 3). This was with the exception ofPlease cite this article in press as: O'Connor L, et al., Intakes and sources of
markers, Clinical Nutrition (2017), http://dx.doi.org/10.1016/j.clnu.2017.0the positive association of sugars from liquids and ln HOMA-IR
which was signiﬁcant only if replacing protein [b-coefﬁcient (95%
CI), 0.07 (0.03,0.12)] and the positive association of sugars from
liquids and ln CRP which was non-signiﬁcant only if replacing
protein [b-coefﬁcient (95%CI), 0.09 (0.01,0.19)].
3.4. Sensitivity and interaction analyses
Using different methods to adjust for energy intake did not
substantially affect the interpretation of the associations
(Supplementary Table 4). In other sensitivity analyses
(Supplementary Table 5), including total sugars from milk (previ-
ously un-categorised) as sugars from liquids or restricting analyses
of HbA1c to participants with levels <6.5%, did not change the di-
rection, magnitude or signiﬁcance of the associations. Excluding
sugar added to tea, coffee, cereal from sugars from solids, shifted the
null association of sugars from solids (per 10%TEI) and all outcomes
towards the inverse, making the association with ln HOMA-IR sig-
niﬁcant [b-coefﬁcient (95%CI), 0.04 (0.06, 0.02)]. As sugar
added to tea, coffee, cereal could not be further differentiated, a
conservative a priori decisionwas made to include it as sugars from
solids. However, intakes of tea and coffeewere higher than of cereal
in the Fenland Study (data not shown), therefore sugar added to tea
or coffee is likely to have contributed the larger proportion.
Including sugar added to tea, coffee, cereal in sugars from liquids,
strengthened the signiﬁcant positive association of sugars from
liquids (per 10%TEI) and all outcomes, including the association of
intake of sugars from liquids and HbA1c which became signiﬁcant
only after this re-categorisation [0.03 (0.01,0.05)].
No signiﬁcant interactions were evident for any of the sugar
exposures with age (p  0.080), sex (p  0.114) or smoking status
(p 0.071). Interaction terms of BMI with liquid, solid and non-free
sugar were signiﬁcant for HbA1c, ln HOMA-IR and the metabolic
risk z-score (Supplementary Table 6a) and of PAEE with solid and
non-free sugars for HbA1c (Supplementary Table 6b). Stratiﬁed
analyses by BMI status (normal weight, overweight, obese) or PAEEdietary sugars and their associationwithmetabolic and inﬂammatory
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Table 1
Population characteristics by consumption category (quintile) of each of sugars from liquids, sugars from solids, free sugars and non-free sugars (%TEI); The Fenland Study, UK
(n ¼ 9678).
Sugars from liquids Sugars from solids Free sugars Non-free sugars
Q1 Q5 Q1 Q5 Q1 Q5 Q1 Q5
Age (year) 48.5 ± 7.2 46.1 ± 7.5* 47.3 ± 7.5 48.2 ± 7.3* 48.8 ± 7.3 46.7 ± 7.4* 46.9 ± 7.4 48.8 ± 7.3*
Sex, men (%) 38.1 48.6* 56.6 34.3* 39.1 52.28* 64.9 30.8*
Marital status, married (%) 60.3 56.4* 57.9 55.7 58.8 55.5 57.5 56.4
Age at completion of full-time
education (year)
18.5 ± 4.1 18.6 ± 3.7* 19.1 ± 4.4 18.6 ± 4.2 19.0 ± 4.5 18.2 ± 3.6* 18.4 ± 4.0 18.8 ± 4.3*
Household income level,
>£40,000 per year (%)
41.1 48.8* 51.2 45.0 49.0 42.1* 43.3 49.2*
Social class, managerial &
professional occupations (%)
48.8 52.8* 55.1 53.1 56.0 47.0* 46.2 56.6*
Smoking status, current (%) 15.2 13.4* 18.9 12.2* 13.3 18.1* 23.3 6.8*
Alcohol consumption
(units/week)
1.6 (0.0,5.2) 5.4 (1.3,11.9)* 8.5 (2.7,24.5) 1.8 (0,5.6)* 4.8 (1.1,9.6) 4.1 (0.7,8.4)* 6.4 (1.4,14.7) 2.7 (0.7,7.5)*
BMI (kg/m2) 26.9 ± 5.1 27.1 ± 4.8* 27.4 ± 4.9 26.6 ± 5.0* 27.0 ± 5.0 27.0 ± 4.9 27.5 ± 5.0 26.7 ± 5.0*
PAEE (kJ/kg/d) 52.3 ± 22.3 55.9 ± 23.7* 54.1 ± 22.8 54.7 ± 24.1 52.1 ± 22.1 57.3 ± 24.6* 56.1 ± 24.0 53.7 ± 22.7*
Dietary exposures
Energy (kJ/d) 7816 ± 2871 8284 ± 2677* 8107 ± 2784 8037 ± 2881* 7217 ± 2522 9418 ± 3392* 9396 ± 3480 7189 ± 2317*
Total fat (%TEI) 34.7 ± 6.7 31.4 ± 5.5* 36.2 ± 6.4 29.5 ± 5.38 33.6 ± 7.0 33.1 ± 5.5* 37.4 ± 5.6 28.5 ± 5.0*
Total protein (%TEI) 18.9 ± 4.0 17.1 ± 3.3* 18.7 ± 3.9 17.4 ± 3.7* 20.5 ± 3.9 15.5 ± 2.9* 16.7 ± 3.8 19.0 ± 3.6*
Total carbohydrates (%TEI) 48.0 ± 7.6 50.2 ± 7.3* 41.6 ± 6.9 54.8 ± 5.5* 44.9 ± 8.3 52.3 ± 5.8* 44.2 ± 7.3 53.5 ± 6.2*
Total sugars (%TEI) 22.2 ± 6.4 26.6 ± 6.1* 16.6 ± 3.9 31.5 ± 4.7* 19.7 ± 6.5 28.7 ± 5.2* 19.4 ± 5.7 29.7 ± 5.3*
Sugars from liquids
(%TEI)
0.5 ± 0.3 7.0 ± 2.9* 3.5 ± 3.2 2.5 ± 2.5* 1.5 ± 1.2 4.9 ± 4.0* 3.2 ± 3.1 2.7 ± 2.5*
Sugars from solids
(%TEI)
21.7 ± 6.4 19.5 ± 5.6* 13.2 ± 2.4 28.9 ± 4.1* 18.2 ± 6.6 23.8 ± 5.5* 16.1 ± 5.2 26.9 ± 5.0*
Free sugars (%TEI) 9.9 ± 4.7 15.6 ± 4.9* 9.4 ± 4.0 14.3 ± 6.2* 6.2 ± 1.4 19.2 ± 3.8* 13.8 ± 5.7 10.2 ± 4.1*
Non-free sugars (%TEI) 12.3 ± 5.9 10.9 ± 5.0* 7.3 ± 2.4 17.2 ± 6.5* 13.6 ± 6.3 9.8 ± 4.2* 5.6 ± 1.3 19.5 ± 4.4*
Starch (%TEI) 24.7 ± 6.2 22.0 ± 4.9* 24.3 ± 6.5 21.3 ± 4.6* 24.2 ± 6.6 21.7 ± 4.6* 23.8 ± 5.7 22.1 ± 5.1*
Fibre, NSP (g/d) 18.0 ± 7.7 16.8 ± 6.7* 15.3 ± 6.5 20.1 ± 8.4* 18.0 ± 8.2 17.0 ± 6.9* 15.2 ± 6.3 21.0 ± 8.5*
Fruit (g/d) 247 ± 223 247 ± 217 118 ± 88 432 ± 305* 278 ± 246 218 ± 200* 89 ± 74 485 ± 290*
Vegetables (g/d) 270 ± 168 256 ± 132* 241 ± 128 287 ± 180* 292 ± 187 243 ± 130* 224 ± 117 313 ± 190*
Total ﬁsh (g/d) 42 ± 38 42 ± 35* 46 ± 42 39 ± 31* 48 ± 41 37 ± 30* 42 ± 40 43 ± 33
Red meat & processed
meat (g/d)
53 ± 43 53 ± 37* 68 ± 51 39 ± 31* 55 ± 48 54 ± 36 72 ± 49 37 ± 30*
SSB (g/d) 4 ± 7 130 ± 173* 52 ± 122 35 ± 90* 9 ± 19 110 ± 172* 75 ± 145 27 ± 73*
Fruit juice (g/d) 7 ± 10 116 ± 123* 54 ± 78 53 ± 78* 29 ± 42 82 ± 111* 51 ± 76 58 ± 82*
Plasma vitamin C (mmol/L) 63.9 ± 23.1 70.9 ± 21.1* 63.4 ± 22.1 71.7 ± 21.2* 68.3 ± 21.8 65.8 ± 22.4* 58.7 ± 23.2 75.3 ± 19.2*
Outcomes
HbA1c (%) 5.5 (5.3,5.7) 5.5 (5.3,5.7)* 5.5 (5.3,5.7) 5.5 (5.3,5.7) 5.5 (5.3,5.7) 5.5 (5.3,5.7) 5.5 (5.3,5.8) 5.5 (5.3,5.7)*
HOMA-IR 1.2 (0.8,1.7) 1.2 (0.8,2.0) 1.3 (0.8,2.0) 1.1 (0.7,1.7)* 1.1 (0.8,1.7) 1.3 (0.8,2.0) 1.4 (0.9,2.2) 1.4 (0.9,2.2)*
CRP (mg/L) 1.34 (0.55,3.23) 1.48 (0.62,3.41) 1.57 (0.65,3.55) 1.28 (0.53,3.06)* 1.39 (0.60,3.27) 1.50 (0.63,3.33) 1.65 (0.65,3.55) 1.26 (0.52,3.06)*
Metabolic risk z score 0.05 ± 1.0 0.08 ± 1.00* 0.16 ± 1.1 0.12 ± 0.96 0.06 ± 1.0 0.11 ± 0.97* 0.26 ± 1.1 0.16 ± 0.98*
* Signiﬁcant p for trend (<0.05) estimated across all ﬁve consumption categories (Q1 through Q5) using ANOVA or chi-square test for independence.
Values are: mean ± SD, median (inter-quartile range) or %.
SSB include soft drinks and fruit squash/juice drink.
Metabolic risk z score: derived by summing the z-scores of the following continuous indices: waist circumference, systolic blood pressure þ diastolic blood pressure, 2 h
plasma glucose, fasting insulin, inverted fasting HDL cholesterol, and triglycerides.
Abbreviations: C-Reactive Protein, CRP; Glycated Haemoglobin, HbA1c; Homeostasis Model Assessment of Insulin Resistance, HOMA-IR; Non-Starch Polysaccharide, NSP;
Percent Total Energy Intake, %TEI; Physical Activity Energy Expenditure, PAEE; Quintiles, Q; Sugar Sweetened beverages, SSB.
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the positive association of sugars from liquids and ln HOMA-IR was
stronger in obese participants [b-coefﬁcient (95%CI), per 10%TEI:
0.14 (0.04,0.40)] than those who were of normal weight or over-
weight [0.04 (0.03,0.10)]. This did not change the overall inter-
pretation of ﬁndings.
3.5. Individual components of the metabolic risk z-score
Intakes of sugars from liquids and of free sugars (per 10%TEI)
were signiﬁcantly (after correction for multiple testing, p  0.0017)
associated with higher fasting insulin, lower HDL cholesterol and
higher triglycerides (Table 3). Intakes of sugars from solids and
non-free sugars were associated with lower HDL cholesterol [per
10%TEI, Model 2: b-coefﬁcient (95%CI), 0.04 (0.05, 0.03)
and 0.03 (0.05, 0.01) respectively]. Intake of non-free sugars
was associated with lower 2-h plasma glucose [0.13
(0.20, 0.05)] and fasting insulin [0.05 (0.07, 0.02)].Please cite this article in press as: O'Connor L, et al., Intakes and sources of
markers, Clinical Nutrition (2017), http://dx.doi.org/10.1016/j.clnu.2017.053.6. Food and beverage contributors
Different foods and beverages contributed to intakes of each of
the sugar intake exposures (Table 4). Sugars (per 10%TEI) in fruit,
vegetables, dairy products and egg dishes, cakes, biscuits and
confectionary, and fruit squash/juice drinks were not signiﬁcantly
(after correcting formultiple testing, p 0.003) associatedwith any
outcome in analyses adjusted for potential confounders, including
BMI, energy intake, dietary quality and mutually adjusted for sugar
from all other sources (Model 2, Table 4). Sugar added to tea, coffee,
cereal was signiﬁcantly positively associated with all outcomes.
Sugars (per 10%TEI) in 100% fruit juice [0.16 (0.06,0.25)] and other
non-alcoholic beverages [0.13 (0.03,0.23)] were positively associ-
ated with the metabolic risk z-score.
Sugars from alcoholic beverages contributed >10% of intake (g/
d) of sugars from liquids. Due to collinearity with alcohol con-
sumption (units/week) in this dataset, we were unable to examine
the association with metabolic and inﬂammatory markers.dietary sugars and their associationwithmetabolic and inﬂammatory
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Table 2
The association of intakes of sugars from liquids, sugars from solids, free sugars and non-free sugars (%TEI) and metabolic & inﬂammatory markers using multiple linear
regression; The Fenland Study, UK (n ¼ 9678).
Sugars from liquids
Q1
n ¼ 1936
Q2
n ¼ 1936
Q3
n ¼ 1935
Q4
n ¼ 1936
Q5
n ¼ 1935
p-trend*
Intake range (%TEI) 0e0.9 0.9e1.9 1.9e2.8 2.8e4.3 4.3e36.0
HbA1c
(%)
Model 1 ref 0.02 (0.04,0.01) 0.02 (0.04,0.01) 0.02 (0.04,0.01) 0.02 (0.01,0.04) 0.058
Model 2 ref 0.02 (0.04,0.01) 0.02 (0.05,0.01) 0.02 (0.05,0.00) 0.00 (0.02,0.03) 0.393
ln
HOMA-IR
Model 1 ref 0.03 (0.00,0.07) 0.04 (0.00,0.07) 0.09 (0.05,0.13)** 0.11 (0.07,0.15)** <0.001
Model 2 ref 0.03 (0.00,0.06) 0.02 (0.01,0.06) 0.07 (0.03,0.10)** 0.06 (0.03,0.10)** <0.001
ln CRP
(mg/L)
Model 1 ref 0.04 (0.03,0.12) 0.05 (0.02,0.13) 0.13 (0.06,0.21)** 0.21 (0.13,0.28)** <0.001
Model 2 ref 0.04 (0.03,0.11) 0.04 (0.03,0.11) 0.10 (0.03,0.17) 0.14 (0.06,0.21)** <0.001
Metabolic
risk z score
Model 1 ref 0.00 (0.05,0.06) 0.06 (0.01,0.12) 0.12 (0.06,0.17)** 0.18 (0.13,0.24)** <0.001
Model 2 ref 0.01 (0.03,0.05) 0.05 (0.01,0.09) 0.08 (0.03,0.12)** 0.11 (0.07,0.15)** <0.001
Free sugars
Q1
n ¼ 1936
Q2
n ¼ 1935
Q3
n ¼ 1936
Q4
n ¼ 1935
Q5
n ¼ 1935
p-trend*
Intake range (%TEI) 0.5e8.0 8.0e10.4 10.4e12.6 12.6e15.5 15.5e46.4
HbA1c
(%)
Model 1 ref 0.01 (0.04,0.02) 0.00 (0.03,0.02) 0.03 (0.00,0.05) 0.00 (0.03,0.03) 0.388
Model 2 ref 0.01 (0.03,0.02) 0.00 (0.02,0.03) 0.03 (0.00,0.05) 0.00 (0.03,0.03) 0.303
ln
HOMA-IR
Model 1 ref 0.03 (0.01,0.07) 0.05 (0.01,0.09) 0.05 (0.01,0.09) 0.07 (0.02,0.11)** 0.002
Model 2 ref 0.04 (0.01,0.07) 0.07 (0.04,0.10)** 0.06 (0.02,0.09)** 0.08 (0.04,0.12)** <0.001
ln CRP
(mg/L)
Model 1 ref 0.00 (0.08,0.07) 0.02 (0.09,0.06) 0.04 (0.04,0.11) 0.08 (0.01,0.16) 0.051
Model 2 ref 0.01 (0.06,0.08) 0.01 (0.06,0.08) 0.05 (0.03,0.12) 0.10 (0.02,0.18) 0.012
Metabolic
risk z score
Model 1 ref 0.03 (0.02,0.08) 0.03 (0.02,0.08) 0.06 (0.00,0.11) 0.11 (0.04,0.17)** <0.001
Model 2 ref 0.05 (0.00,0.09) 0.06 (0.02,0.10)** 0.07 (0.03,0.11)** 0.13 (0.08,0.17)** <0.001
*p-trend was estimated by including the median value of each quintile as a continuous variable.
Values are b-coefﬁcients (95% conﬁdence intervals).
Model 1 was adjusted for age, sex, years of education, income level, social class, smoking status, alcohol consumption (units/week), test site, PAEE, clinical history (self-
reported hypertension or use of anti-hypertensive medication or self-reported hyperlipidaemia or use of lipid lowering medication), weight-loss diet, ﬁbre (NSP) intake,
plasma vitamin C measurement, non-sugar containing beverage intake (tea, coffee, artiﬁcially sweetened beverages) and low-nutrient energy-dense food intake (buns,
cakes, puddings, biscuits, pastries, chocolate and non-chocolate confectionary and ice-cream).
Model 2 was additionally adjusted for BMI, total energy intake and sugars (sugars from liquids were additionally adjusted for sugars from solids and vice versa, and free
sugars were additionally adjusted for non-free sugars and vice versa).
Estimates after adjustment for BMI and total energy intake without adjustment for sugars, did not differ from the most adjusted model.
Metabolic risk z score: derived by summing the z-scores of the following continuous indices: waist circumference, systolic blood pressure þ diastolic blood pressure, 2 h
plasma glucose, fasting insulin, inverted fasting HDL cholesterol, and triglycerides.
**Signiﬁcant after correction for multiple testing, p  0.003.
Abbreviations: C-Reactive Protein, CRP; Glycated Haemoglobin, HbA1c; Homeostasis Model Assessment of Insulin Resistance, HOMA-IR; Non-Starch Polysaccharide, NSP;
Percent Total Energy Intake, %TEI; Physical Activity Energy Expenditure, PAEE; Quintiles, Q.
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Participants classiﬁed as obese reported consuming less sugars
from solids, non-free sugars, fruit, fruit juice, and alcoholic bever-
ages, and more sugars from liquids, dairy products and egg dishes,
fruit squash/juice drinks and non-alcoholic beverages than normal
weight individuals (Supplementary Table 7). There was no signiﬁ-
cant trend in consumption of free sugars or of sugar added to tea,
coffee, cereal across BMI categories.4. Discussion
4.1. Summary of ﬁndings
Intakes of sugars from liquids and of free sugars were adversely
associated with glycaemia and inﬂammatory makers. In contrast,
intakes of sugars from solids and non-free sugars were either
inversely, or not, associated with individual markers. Associations
were similar whether sugars were replaced with fat; protein; pol-
yols, oligosaccharides and starch; or a combination of macronu-
trients. Examining the major food and beverage contributors to
sugar intakes indicated that the positive associations reported for
free sugars were explained by the contribution of beverages to free
sugar intake. Moreover, sugars from foods were not associated withPlease cite this article in press as: O'Connor L, et al., Intakes and sources of
markers, Clinical Nutrition (2017), http://dx.doi.org/10.1016/j.clnu.2017.0glycaemia and inﬂammatory markers irrespective of whether they
were free or non-free sugars.4.2. Current ﬁndings in context
There are few data with which to compare our results. In
keeping with our ﬁndings of a positive association of sugars from
liquids and adverse metabolic markers, a study of American adults
reported a positive association of sugar intake from beverages and
mortality risk along with an inverse association of sugars from
foods [20]. A second study of Canadian youth at risk of obesity re-
ported an association of added sugars from liquid sources but not
solid sources with higher fasting glucose and insulin levels [21].
Our ﬁndings are in line with the substantial evidence for sugar-
sweetened beverage intake and adverse metabolic outcomes
[8,22e27]. Previous studies have reported different associations for
different sweet beverages [9,28] including both positive [29,30] and
null associations [31,32] for fruit juice intake. We observed signif-
icant positive associations for sugars from fruit juice and other non-
alcoholic beverages, and a non-signiﬁcant trend toward positive
associations for sugars from fruit squash/juice drinks, which could
possibly be explained by there being fewer consumers of fruit
squash/juice drinks (n ¼ 5135) than fruit juice consumers
(n ¼ 7922). The consistent ﬁndings for all non-alcoholic beverages
in this study may be because we examined only the sugar intakedietary sugars and their associationwithmetabolic and inﬂammatory
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Sugars from solids
Q1
n ¼ 1936
Q2
n ¼ 1936
Q3
n ¼ 1935
Q4
n ¼ 1936
Q5
n ¼ 1935
p-trend*
2.4e15.9 16.0e18.9 19.0e21.6 21.6e24.8 24.8e56.5
ref 0.03 (0.06,0.01) 0.01 (0.04,0.02) 0.04 (0.06,0.01) 0.02 (0.04,0.01) 0.357
ref 0.02 (0.05,0.00) 0.00 (0.02,0.03) 0.02 (0.05,0.01) 0.01 (0.02,0.04) 0.445
ref 0.02 (0.06,0.02) 0.04 (0.08,0.00) 0.08 (0.12,0.04)** 0.08 (0.12,0.04)** <0.001
ref 0.01 (0.02,0.04) 0.00 (0.03,0.04) 0.02 (0.05,0.02) 0.02 (0.06,0.02) 0.109
ref 0.04 (0.11,0.04) 0.06 (0.14,0.02) 0.03 (0.10,0.05) 0.09 (0.17,0.01) 0.067
ref 0.01 (0.06,0.08) 0.00 (0.07,0.07) 0.06 (0.01,0.14) 0.00 (0.07,0.08) 0.601
ref 0.06 (0.11,0.00) 0.07 (0.13,0.02) 0.07 (0.13,0.02) 0.08 (0.13,0.02) 0.014
ref 0.01 (0.05,0.03) 0.02 (0.06,0.02) 0.02 (0.03,0.06) 0.01 (0.04,0.05) 0.474
Non-free sugars
Q1
n ¼ 1936
Q2
n ¼ 1935
Q3
n ¼ 1936
Q4
n ¼ 1935
Q5
n ¼ 1935
p-trend*
0.6e7.3 7.3e9.6 9.6e11.9 11.9e15.2 15.2e54.6
ref 0.02 (0.04,0.01) 0.03 (0.06,0.00) 0.02 (0.05,0.01) 0.03 (0.06,0.00) 0.127
ref 0.01 (0.04,0.01) 0.02 (0.05,0.01) 0.01 (0.04,0.02) 0.01 (0.05,0.02) 0.616
ref 0.03 (0.07,0.01) 0.03 (0.07,0.01) 0.07 (0.11,0.03)** 0.09 (0.13,0.05)** <0.001
ref 0.02 (0.06,0.01) 0.02 (0.05,0.01) 0.04 (0.07,0.00) 0.07 (0.11,0.03)** 0.001
ref 0.00 (0.07,0.08) 0.01 (0.07,0.08) 0.04 (0.12,0.04) 0.03 (0.12,0.06) 0.719
ref 0.01 (0.06,0.08) 0.03 (0.05,0.10) 0.01 (0.06,0.09) 0.00 (0.08,0.09) 0.999
ref 0.03 (0.08,0.03) 0.03 (0.09,0.02) 0.07 (0.13,0.02) 0.04 (0.10,0.02) 0.122
ref 0.02 (0.06,0.02) 0.02 (0.06,0.03) 0.03 (0.08,0.01) 0.03 (0.08,0.02) 0.306
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grouping beverages with different amounts of sugar per serving
and ensures that beverage exposures are comparable e.g. for
portion size.
Estimated intake of free sugars was positively associated with
HOMA-IR and metabolic risk; however the associations were
limited to free sugars from 100% fruit juice and other non-alcoholic
beverages. Restriction of intakes of free sugars is advocated in di-
etary guidelines [1,5] as they are usually contained in energy dense
nutrient poor foods and are associated with obesity through their
contribution to energy intake. Our ﬁndings are consistent with
these recommendations, but they speciﬁcally support a focus on
sugars from liquids in terms of preventing potential adverse
metabolic risk.
Milk sugars were not comprehensively evaluated in these ana-
lyses as we were unable to discern whether milk was consumed as
a beverage or as part of a food. In sensitivity analyses we included
total sugars from milk as sugars from liquids and highlighted the
possibility of an inverse association with HOMA-IR, CRP and the
metabolic risk. Given these results and the inverse associations
reported for certain dairy product intake and metabolic diseases
including type 2 diabetes [33e35], this associationwarrants further
investigation.4.3. Mechanisms
The biological mechanisms by which sugars consumed from
beverages may adversely affect metabolic and inﬂammatory
markers are unknown. Given that there are no chemical differences
between these sugars and sugars found in foods, we hypothesise
that the adverse metabolic proﬁle with sugars from liquids may
relate to the large quantity of rapidly absorbable sugars that can be
consumed in a relatively short period of time, similar to the hy-
pothesis previously proposed for sugar-sweetened beverages and
adversemetabolic outcomes [24]. A secondhypothesis is thatmono-
and di-saccharides (other than lactose)may have adversemetabolic
effects but the effect of sugar in food is offset by the co-assimilationPlease cite this article in press as: O'Connor L, et al., Intakes and sources of
markers, Clinical Nutrition (2017), http://dx.doi.org/10.1016/j.clnu.2017.05of other nutrients and compounds e.g. ﬁbre. Our analyses provides
some evidence to support this hypothesis as ﬁbre intakes were
signiﬁcantly higher (þ5 g/d) in the highest quintile of sugar from
solids and non-free sugars intake compared with the lowest.4.4. Strengths and limitations
The Fenland Study was designed to be representative of the
Cambridgeshire region, and population characteristics are
congruent with the region's demographic characteristics. However,
the sample is somewhat healthier than the England average, in
particular for obesity and healthy eating [36]. The Fenland Study is a
well-phenotyped study with a wide range of socio-demographic,
dietary, physical activity, general health, anthropometric, meta-
bolic and inﬂammatory marker data available including objectively
measured physical activity and plasma vitamin C. Although we
cannot rule out residual confounding, the availability of detailed
data enable the comprehensive adjustment for confounders and to
account for biases from participants reporting non-typical diets e.g.
those with hypertension and hyperlipidaemia (post-diagnosis
changes) and those who reported being on a weight-loss diet.
Furthermore, there was no indication of selection bias in these
analyses as population characteristics of participants included and
excluded from the analyses were broadly similar.
Due to the cross-sectional study design we cannot determine
the direction of the associations. It is possible that participants
classiﬁed as obese (and therefore at higher risk of metabolic risk)
preferentially consume more sugary foods. In this study, no clear
trend emerged to suggest obese participants report consuming
more sugary foods leading us to hypothesise that reverse causation
is not a likely explanation for our ﬁndings. However, we cannot rule
out the possibility that there may be possible selective under-
reporting of sugary food intake among obese participants, and if
so, it would likely have attenuated the results towards the null
resulting in an underestimation of the associations.
A beneﬁt of using FFQ-derived intake data for these analyses is
that FFQs rank individuals well according to habitual intake.dietary sugars and their associationwithmetabolic and inﬂammatory
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Fig. 2. The association of intakes of sugars (per 10%TEI) and metabolic & inﬂammatory markers using multiple linear regression; the Fenland Study, UK (n ¼ 9678). Values are b-
coefﬁcients (95% conﬁdence intervals). Adjusted for age, sex, years of education, income level, social class, smoking status, alcohol consumption (units/week), test site, PAEE, clinical
history (self-reported hypertension or use of anti-hypertensive medication or self-reported hyperlipidaemia or use of lipid lowering medication), weight-loss diet, ﬁbre (NSP)
intake, plasma vitamin C measurement, non-sugar containing beverage intake (tea, coffee, artiﬁcially sweetened beverages), low-nutrient energy-dense food intake (buns, cakes,
puddings, biscuits, pastries, chocolate and non-chocolate confectionary and ice-cream), BMI, total energy intake and mutually adjusted for sugars (Model 2).A Signiﬁcant after
correction for multiple testing, p  0.003. Metabolic risk z score: derived by summing the z-scores of the following continuous indices: waist circumference, systolic blood
pressure þ diastolic blood pressure, 2 h plasma glucose, fasting insulin, inverted fasting HDL cholesterol, and triglycerides; Abbreviations: C-Reactive Protein, CRP; Glycated
Haemoglobin, HbA1c; Homeostasis Model Assessment of Insulin Resistance, HOMA-IR; Non-Starch Polysaccharides, NSP; Percent total energy intake, %TEI; Physical Activity Energy
Expenditure, PAEE.
Table 3
The association of intakes of sugars from liquids, sugars from solids, free sugars and non-free sugars (%TEI) and individual components of the metabolic risk z score using
multiple linear regression; The Fenland Study, UK (n ¼ 9768).
Sugars from liquids Sugars from solids Free sugars Non-free sugars
Mean (range), %TEI 2.9 (0e36.0) 20.6 (2.4e56.5) 12.0 (0.5e46.4) 11.5 (0.6e54.6)
per 10%TEI
Waist circumference (cm) 0.28 (0.15,0.71) 0.21 (0.44,0.01) 0.15 (0.13,0.43) 0.32 (0.60,0.05)
Systolic blood pressure (mmHg) 1.81 (0.73,2.89)* 0.07 (0.64,0.49) 0.43 (0.27,1.12) 0.22 (0.47,0.90)
Diastolic blood pressure (mmHg) 1.29 (0.57,2.02)* 0.28 (0.66,0.10) 0.31 (0.15,0.77) 0.18 (0.63,0.28)
2 h plasma glucose (mmol/l) 0.16 (0.04,0.28) 0.08 (0.15,0.02) 0.07 (0.01,0.15) 0.13 (0.20,0.05)*
ln Fasting insulin (rmol/l) 0.04 (0.02,0.08)* 0.01 (0.03,0.01) 0.05 (0.02,0.07)* 0.05 (0.07,0.02)*
HDL cholesterol (mmol/l) 0.04 (0.07,0.02)* 0.04 (0.05,0.03)* 0.05 (0.06,0.03)* 0.03 (0.05,0.01)*
ln Triglycerides (mmol/l) 0.07 (0.01,0.13)* 0.01 (0.02,0.02) 0.06 (0.04,0.09)* 0.02 (0.05,0.00)
Values are b-coefﬁcients (95% conﬁdence intervals).
Adjusted for age, sex, years of education, income level, social class, smoking status, alcohol consumption (units/week), test site, PAEE, clinical history (self-reported hyper-
tension or use of anti-hypertensive medication or self-reported hyperlipidaemia or use of lipid lowering medication), weight-loss diet, ﬁbre (NSP) intake, plasma vitamin C
measurement, non-sugar containing beverage intake (tea, coffee, artiﬁcially sweetened beverages), low-nutrient energy-dense food intake (buns, cakes, puddings, biscuits,
pastries, chocolate and non-chocolate confectionary and ice-cream), BMI, total energy intake and mutually adjusted for sugars (Model 2).
Metabolic risk z score: derived by summing the z-scores of the following continuous indices: waist circumference, systolic blood pressure þ diastolic blood pressure, 2 h
plasma glucose, fasting insulin, inverted fasting HDL cholesterol, and triglycerides.
*Signiﬁcant after correction for multiple testing, p  0.0017.
Abbreviations: C-Reactive Protein, CRP; Glycated Haemoglobin, HbA1c; Homeostasis Model Assessment of Insulin Resistance, HOMA-IR; Non-Starch Polysaccharide, NSP;
Percent Total Energy Intake, %TEI; Physical Activity Energy Expenditure, PAEE.
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Table 4
The association of intakes of each of sugars from liquids, sugars from solids, free sugars and non-free sugars (%TEI) frommajor food and beverage contributors* andmetabolic&
inﬂammatory markers using multiple linear regression; The Fenland Study, UK (n ¼ 9678).
Contribution
to intake of
sugars (g/d)
Mean (range),
%TEI
n
consumers**
HbA1c (%) ln HOMA-IR ln CRP (mg/L) Metabolic risk
z score
per 10%TEI
Sugars from liquids 2.9 (0e36.0) 0.00 (e0.03,0.03) 0.05 (0.01,0.09) 0.14 (0.05,0.22)*** 0.13 (0.07,0.18)***
Fruit squash/juice drink 33% 0.9 (0e22.0) 5135 0.03 (0.02,0.08) 0.05 (e0.01,0.11) 0.12 (e0.00,0.25) 0.07 (e0.01,0.14)
Fruit juice (100%)a 33% 1.1 (0e16.4) 7922 0.04 (0.10,0.02) 0.06 (0.01,0.14) 0.10 (0.06,0.26) 0.16 (0.06,0.25)***
Non-alcoholic beverages 20% 0.6 (0e23.9) 7172 0.00 (0.06,0.07) 0.00 (0.08,0.08) 0.11 (0.05,0.28) 0.13 (0.03,0.23)***
Alcoholic beveragesb 13% 0.5 (0e4.8) 7900 0.34 (0.55,0.14)*** 0.54 (0.79,0.29)*** 0.54 (0.01,1.08) 0.42 (0.75,0.10)
Sugars from solids 20.0 (2.2e56.5) 0.00 (0.01,0.02) 0.01 (0.04,0.01) 0.01 (0.06,0.03) 0.00 (0.02,0.03)
Cakes, biscuits &
confectionary
29% 5.3 (0e44.9) 9625 0.01 (0.03,0.04) 0.01 (0.04,0.05) 0.13 (0.22,0.04) 0.00 (0.05,0.06)
Fruit 29% 5.9 (0e52.1) 9542 0.00 (0.03,0.02) 0.04 (0.07,0.01) 0.05 (0.11,0.01) 0.03 (0.06,0.01)
Dairy products & egg
dishes
21% 4.3 (0e20.0) 9655 0.00 (0.04,0.03) 0.04 (0.09,0.00) 0.03 (0.07,0.13) 0.02 (0.08,0.04)
Sugar added to tea,
coffee, cereal
15% 1.2 (0e15.1) 3668 0.06 (0.02,0.10)*** 0.12 (0.07,0.17)*** 0.25 (0.14,0.36)*** 0.18 (0.12,0.25)***
Free sugars 11.8 (0.4e46.4) 0.01 (0.01,0.03) 0.05 (0.03,0.08)*** 0.07 (0.01,0.12) 0.09 (0.06,0.12)***
Cakes, biscuits &
confectionary
44% 5.1 (0e44.8) 9625 0.03 (0.02,0.08) 0.05 (0.01,0.11) 0.12 (0.00,0.25) 0.07 (0.00,0.15)
Sugar added to tea,
coffee, cereal
25% 1.2 (0e15.1) 3668 0.06 (0.02,0.10)*** 0.12 (0.07,0.17)*** 0.25 (0.14,0.36)*** 0.18 (0.12,0.25)***
Fruit squash/juice drink 13% 0.9 (0e22.0) 5135 0.03 (0.02,0.08) 0.05 (0.01,0.11) 0.12 (0.00,0.25) 0.07 (0.01,0.14)
Fruit juice (100%)a 10% 1.1 (0e16.4) 7922 0.04 (0.10,0.02) 0.06 (0.01,0.14) 0.10 (0.06,0.26) 0.16 (0.06,0.25)***
Non-free sugars 11.7 (0.6e54.6) 0.01 (0.03,0.01) 0.05 (0.07,0.02)*** 0.03 (0.08,0.03) 0.03 (0.06,0.01)
Fruit 50% 5.8 (0e52.1) 9542 0.00 (0.03,0.02) 0.04 (0.07,0.01) 0.05 (0.11,0.01) 0.03 (0.06,0.01)
Dairy products & egg dishes 28% 3.3 (0e16.8) 9655 0.00 (0.05,0.04) 0.06 (0.12,0.00) 0.02 (0.11,0.14) 0.01 (0.08,0.06)
Vegetables 11% 1.3 (0e9.5) 9667 0.01 (0.16,0.15) 0.20 (0.01,0.39) 0.40 (0.00,0.81) 0.12 (0.12,0.36)
*Foods or beverages that contributed greater than 10% to each sugar intake (g/d) exposure.
**Non-consumers included as 0%TEI.
Adjusted for age, sex, years of education, income level, social class, smoking status, alcohol consumption (units/week), test site, PAEE, clinical history (self-reported hyper-
tension or use of anti-hypertensive medication or self-reported hyperlipidaemia or use of lipid lowering medication), weight-loss diet, ﬁbre (NSP) intake, plasma vitamin C
measurement, non-sugar containing beverage intake (tea, coffee, artiﬁcially sweetened beverages), low-nutrient energy-dense food intake (buns, cakes, puddings, biscuits,
pastries, chocolate and non-chocolate confectionary and ice-cream), BMI, total energy intake and mutually adjusted for sugars from all other sources (Model 2).
***Signiﬁcant after correction for multiple testing, p  0.003.
Metabolic risk z score: derived by summing the z-scores of the following continuous indices: waist circumference, systolic blood pressure þ diastolic blood pressure, 2 h
plasma glucose, fasting insulin, inverted fasting HDL cholesterol, and triglycerides.
Abbreviations: C-Reactive Protein, CRP; Glycated Haemoglobin, HbA1c; Homeostasis Model Assessment of Insulin Resistance, HOMA-IR; Non-Starch Polysaccharide, NSP;
Percent Total Energy Intake, %TEI; Physical Activity Energy Expenditure, PAEE.
a Not adjusted for plasma vitamin C.
b Adjustment for a categorical alcohol consumption (quintiles) variable in place of continuous variable (units/week) due to collinearity.
L. O'Connor et al. / Clinical Nutrition xxx (2017) 1e10 9However, as the FFQ is semi-quantitative our estimates of intake
should be interpreted relative to each other and not as absolute
intake values. Additionally, some misclassiﬁcation might occur as
estimates by FFQ were imperfect (e.g. r ¼ 0.51 for total sugars,
compared to estimates by 16-day food records) [12] and as expo-
sures of different types of sugars were estimated post-hoc.
Although our approach was comprehensive and the most detailed
to date to our knowledge, some foods are inherently difﬁcult to
classify for example fruit juice in unsweetened tinned fruit.5. Conclusion
In a large population-based cohort, higher intakes of sugars
from non-alcoholic beverages and sugar added to tea, coffee, or
cereal were associated with glycaemia and inﬂammatory markers,
while sugars from foods, regardless of whether they were free or
non-free sugars, were not associated. The positive associations re-
ported here for free sugars were largely explained by the contri-
bution of beverages to free sugar intake. This raises the possibility
that adverse metabolic risk associated with sugar intake, inde-
pendent of contribution to caloric intake, may be attributable to
sugar intake from beverages. The current ﬁndings should stimulate
the identiﬁcation of biological mechanisms and also help to further
inform dietary public health messages on sugars intake.Please cite this article in press as: O'Connor L, et al., Intakes and sources of
markers, Clinical Nutrition (2017), http://dx.doi.org/10.1016/j.clnu.2017.05Funding sources
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